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Heart failure is one of the leading causes of high morbidity and mortality. Acute exacerbation
of heart failure may result in acute respiratory failure, which requires mechanical ventilator
support. Despite supportive management, patients can fail extubation of the endotracheal
tube and need a tracheostomy to continue mechanical ventilator support. However, optimal
timing of tracheostomy has been controversial. Systemic study to assess the clinical and
economic outcome of early tracheostomy among patients with acute heart failure
exacerbation is lacking. The purpose of the study was to assess the national trend of
tracheostomy among those who are admitted for acute respiratory failure with acute
congestive heart failure exacerbation and to compare clinical and economic outcomes
between the two groups (early and late tracheostomy) using national discharge data between
from 2005 to 2014. We also conducted an economic evaluation comparing early and late
tracheostomy among them using average cost and incremental costs with an outcome of

length of stay. Among those who are admitted with acute heart failure exacerbation, 0.30%
patients underwent the tracheostomy, and among them, 9.69% received early tracheostomy.
There was no trend in the percentage of early tracheostomy. The length of stay in the hospital
has decreased over time in late tracheostomy group, but it was stable in early tracheostomy
group. Median total hospital length of stay (19 days) and total hospital cost ($52,158.23) in
early tracheostomy group were significantly lower than late tracheostomy group (25 days and
$68,037.40). Patients with coronary artery disease, pneumonia, and liver disease are less
likely to receive early tracheostomy (OR 0.79, 0.63 and 0.64 respectively). After propensity
score matching, it showed that the two groups did not show a significant difference in inhospital mortality (OR 0.91, p-value 0.676), or decannulation rate (OR 2.01, p-value 0.571).
However, early tracheostomy was associated with higher likelihood of having a complication
from tracheostomy with OR 2.08 (p-value 0.044) but was also associated with lower total
hospital length of stay with coefficient factor -6.50 (p-value 0.000) from the linear regression
model. From the economic evaluation, the early tracheostomy dominates the late
tracheostomy with the outcome of total hospital length of stay and post-procedural length of
stay with lower cost and higher effectiveness. The incremental cost-effectiveness ratio
(ICER) is negative, meaning it costs $3,492.65 for each additional day in the hospital for late
tracheostomy compared to early tracheostomy. ICER with the outcome of post-procedural
length of stay was again negative, showing $2,032.67 per extra day in the hospital after the
procedure among late tracheostomy group. Early tracheostomy among patients with acute
heart failure exacerbation had no significant difference in mortality but had significant
economic benefit with lower cost and less total hospital length of stay.
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BACKGROUND
Heart failure is one of the leading causes of high morbidity and mortality. Based on the data
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That
number is anticipated to increase 46% from 2012 to 2030, which can result in more than 8
million people older than 18 years of age with heart failure. 1 One in nine deaths has heart
failure on the death certificates, according to the National Center for Health Statistics in
2013. 2 Acute exacerbation of heart failure may result in acute respiratory failure, which
requires mechanical ventilator support. Despite supportive management, patients can fail
extubation of the endotracheal tube and need a tracheostomy to continue mechanical
ventilator support.
Tracheostomy usually is done to minimize the mechanical trauma to the larynx or trachea,
facilitate the weaning process, or protect the airway for a long time. Predictors of
tracheostomy have been mostly reported among trauma or surgical patients, but it has not
been studied among patients with acute respiratory failure from acute heart failure
exacerbation. Also, there has not been a systemic study to assess the optimal timing of
tracheostomy among them. Studies have shown that early tracheostomy reduces the hospital
stay without clinical outcome difference.

Literature Review
•

Background
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Heart failure is one of the leading causes of high morbidity and mortality. Based on the data
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That
number is anticipated to increase 46% from 2012 to 2030, which can result in more than 8
million people older than 18 years of age with heart failure. 1 One in nine deaths has heart
failure on the death certificates, according to the National Center for Health Statistics in
2013. 2 Data from Framingham Heart Study indicated that its incidence reached 10 per 1000
population after the age of 65. 3 Even though overall mortality from cardiovascular disease
has declined, heart failure is the only major cardiovascular disease whose prevalence and
incidence is still increasing with poor long term-prognosis. 4-6 Approximately half of the
people who were diagnosed with heart failure die within 5 years. 7
•

The burden of heart failure

Considering the development and implementation of life-prolonging interventions along with
the growing elderly population, the number of individuals with heart failure will be
significantly increased, which will also increase the cost of heart failure. 7,8 In 2012, the
estimate of heart failure related direct cost was $20.9 billion, and the indirect cost was $9.80
billion. 4,7 By 2030, it is anticipated that the total cost will increase to $69.7 billion which
will equal $244 for every United States adult. Costs of heart failure are mainly driven by
hospitalization, home nursing, hospice care, medical devices including cardiac
resynchronization, ventricular assist device, and transplantation. 8 A study using 10-year data
from the National Medical Expenditure Panel Survey (2002-2011) showed that individuals
with heart failure had 4 times higher yearly expenditure ($23,854) compared to those
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without heart failure ($5,511). Heart failure-related costs increased by $5,836 (28% relative
increase), from $21,316 in 2002 to $27,152 in 2010. The single largest driving component of
this increase was inpatient costs ($11,318). 8
•

Acute respiratory failure due to acute congestive heart failure exacerbation

Acute congestive heart failure is a common but potentially fatal condition, caused by
congestive heart failure and may result in acute respiratory failure. It is characterized by
acute dyspnea caused by acute fluid accumulation in the lungs. Most of the times, it is caused
by a rapid increase in hydrostatic pressure in the pulmonary capillaries due to elevated
cardiac filling pressure. This condition is also called cardiogenic pulmonary edema. 9 In
treating patients with acute congestive heart failure exacerbation, routine oxygen
supplementation is not indicated, but if the patient demonstrates hypoxemia (SpO2 <90%),
oxygen supplementation should be initiated. 10 If the patient still shows respiratory distress,
the patient will need assisted ventilation. First line treatment is a trial of noninvasive
ventilation. However, if noninvasive ventilation is contraindicated or patient fails to improve
with noninvasive ventilation within 1-2 hours, the patient should be intubated for
conventional mechanical ventilation.
•

Mechanical ventilation for treatment of respiratory failure

A mechanical ventilator is a machine, which assists or replaces the patient’s spontaneous
breathing using positive pressure. Mechanical ventilation for respiratory failure due to
congestive heart failure exacerbation is usually initiated to reverse life-threatening
hypoxemia (low oxygen level in blood), to provide sufficient oxygen delivery to vital organs,

3

to maintain alveolar stability, and to decrease the work of breath to prevent respiratory
muscle fatigue. 11,12 For the patient to receive mechanical ventilation, the patient should have
a special form of a device, which allows the patient's airway to be directly connected to the
mechanical ventilator. Usually, this special airway is achieved through the procedure
"endotracheal intubation" in an emergent situation. Endotracheal intubation is a procedure to
place a plastic tube in the patient's trachea, which can be connected to the mechanical
ventilator to make a circuit for mechanical ventilation. 13 (Figure 1) The tube may be made of
rubber or plastic and usually has a balloon cuff to keep the tube in place and closed system
with the ventilator.
Figure 1. Endotracheal intubation
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•

The role of tracheostomy

Despite ongoing treatment for congestive heart failure, not all the patients can be weaned off
the ventilator. In such cases, the health care providers should consider tracheostomy. 11,14
(Figure 2) Tracheostomy is a procedure to make an external artificial opening to the trachea.
It could be done as a traditional surgical procedure in an operating room, or it also could be
done at the bedside using percutaneous method. 15-19 Tracheostomy is considered to be
beneficial among the patients who need prolonged mechanical ventilation, as it is thought to
be more comfortable for the patients, requires less sedation, and provides more stable airway
compared to an endotracheal tube. 11 However, tracheostomy does carry several
complications, such as bleeding, cardiopulmonary arrest, hypoxia, structural damage,
pneumothorax, pneumomediastinum, infection, tracheal stenosis, granulation and erosion of
the innominate artery. 11 Hence, the optimal time for tracheostomy with the goal of getting
extubated, and also to prevent complications from prolonged intubation and to secure more
stable airway, has been controversial. 15,20 However, tracheostomy is typically done between
10th and 14th days of intubation. 15,21 Also, there is no clear definition when is “early”
tracheostomy or “late” tracheostomy. Moreover, there is also no clear evidence supporting
the optimal timing of tracheostomy. 22-24 However, some studies have shown a benefit of
early tracheostomy with shorter hospital stays, shorter length of stay in the intensive care
unit, and shorter duration of mechanical ventilation. However, benefit in overall mortality is
still controversial. 25-28 Furthermore, most of the studies comparing early and late
tracheostomy are done among trauma patients or excluded certain underlying respiratory
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conditions. A specific study investigating the optimal timing for patients with respiratory
failure due to congestive heart failure acute exacerbation is lacking.
Figure 2. Tracheostomy

14

,

•

Comparison early and late tracheostomy

Several studies are comparing early and late tracheostomy to assess various outcomes, but
those studies have shown inconsistent outcomes, or their outcomes do not provide strong
evidence due to heterogeneity of the study populations and outcome variables. 15,21-24,26,29-41
Most of the studies focus on trauma patients or were conducted at surgical care unit, 2126,29,35,36,38-40,42

and several studies have included critically ill medical patients. 33,34,37,40,41

Furthermore, those studies included patients with various reasons for intubation. 15,30,31,34,40
Most recently, Andriolo et al. published a systematic review comparing early and late
tracheostomy in critically ill patients. 15 However, they reported mortality result from
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individual studies rather than reporting the result from the review, because of the
inconsistency and the possibility of substantial statistical heterogeneity among the studies.
Rumbak et al. conducted a prospective randomized trial comparing early and late
tracheostomy among patients in a medical intensive care unit, and reported a significant
mortality benefit (31.7% vs. 61,7%) and less pneumonia (5% vs. 25%), for the early cohort.
37

Young et al. also conducted a randomized control clinical trial comparing early and late

tracheostomy, but there was no significant difference in mortality (30.8% vs. 31.5%). 33
From another randomized controlled trial, Zheng et al. also reported no significant difference
in mortality between the two groups. 32 Studies have also used various clinical outcome
variables. For example, Terragni et al. used outcome as prevention of ventilator-associated
pneumonia and found out that early tracheostomy did not result in significant improvement
in preventing ventilator-associated pneumonia. 34 Young et al. also included several
outcomes in the systematic review, other than 30-day mortality, such as two-year mortality,
medical intensive care unit length of stay and tracheostomy-related complications. 33 Several
studies are comparing the duration of mechanical ventilation, and most of them reported a
shorter duration of mechanical ventilation among early tracheostomy groups, but with mixed
statistical significance. 32-34,37

Public Health Significance
Considering the significant economic burden of acute heart failure exacerbation and
subsequent respiratory failure requiring intubation, an optimal strategy to manage those
patients should be investigated. Liu et al. reported cost-effectiveness of early versus late
tracheostomy with the outcome of tracheostomy prevented and it showed that early
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tracheostomy could be more cost-effective with a willingness to pay threshold of $80,000 per
tracheostomy avoided. 30 Other studies have shown that early tracheostomy may provide less
mortality and fewer healthcare resources utilization. However, most of the studies included
heterogeneous clinical conditions in their outcome assessment. Furthermore, to the best of
our knowledge, studies comparing early and late tracheostomy for patients with acute
respiratory failure due to congestive heart failure are lacking. The result of the study will
provide evidence to assist both clinicians and hospital administrator in determining the most
efficient care strategy for managing patients with respiratory failure from acute heart failure
exacerbation requiring ventilator assistance.

Hypothesis, Research Question, Specific Aims or Objectives
The purpose of the study is to assess the national trend of tracheostomy among those who are
admitted for acute respiratory failure with acute congestive heart failure exacerbation and to
compare clinical and economic outcomes between the two groups (early and late
tracheostomy) using propensity score matching. Lastly, we will conduct an economic
evaluation comparing early and late tracheostomy among them using average and
incremental costs with an outcome of length of stay.
•

Objectives
o Aim 1. To identify the national trend of tracheostomy among those who
developed respiratory failure with acute congestive heart failure exacerbation.
§

Trend of tracheostomy use– early (<7 days) vs. late (≥7 days)

§

Identify the predictors of tracheostomy – early vs. late
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o Aim 2: Compare the two groups (early vs. late) in outcomes – in-hospital
mortality, total hospital length of stay and total hospital cost.
o Aim 3: Economic evaluation of early and late tracheostomy among those who
developed respiratory failure with acute congestive heart failure exacerbationaverage and incremental costs with outcome of total hospital length of stay,
and post-procedural length of stay.

METHODS
Conceptual Model
We used the conceptual model for health service research, introduced by Begley et al. (Table
1). 43 This conceptual model provides frameworks and methods for assessing health services
and system with the three objectives: effectiveness, efficiency, and equity. Effectiveness
evaluates the intended and desired outcomes by the health services, such as mortality or life
expectancy, but is not limited to health outcome but also includes the impact of health
outcomes such as quality of life or well-being. The second objective, efficiency, is to monitor
and assess both production efficiency and allocative efficiency of a certain health care
service. It evaluates the health care service whether it maximized the performance with the
minimum cost with an optimal combination of investments. Equity focuses on distributional
fairness in the delivery of the health service. Eventually, those three objectives provide the
criteria for evaluating the health services overall performances. This study's each goal fits
each perspective of health service research as below. (Table 2)

9

Table 1. Definitions of Effectiveness, Efficiency, and Equity Criteria
Level of analysis
Criteria

Clinical

Population

Clinical effectiveness: Improving
the health of individual patients
through the delivery of healthcare
services

Population effectiveness:
Improving the health of
populations through medical or
nonmedical services

Efficiency

Production efficiency: Combining
inputs to produce services at the
lowest cost

Production efficiency: combining
inputs to produce services at the
lowest cost
Allocative efficiency: Combining
health services and other healthrelated investments to produce
maximum health given available
resources

Equity

Procedural equity: Maximizing the
fairness in the distribution of
services across individuals
Substantive equity: Minimizing
the disparities in the distribution
of health across individuals

Procedural equity: Maximizing the
fairness in the distribution of
services across groups
Substantive equity: Minimizing
the disparities in the distribution
of health across groups

Effectiveness
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Table 2. Conceptual model for each aim in this study

Level of analysis
Criteria

Clinical

Aim

Effectiveness

Clinical effectiveness: Improving
the health of individual patients
through the delivery of healthcare
services

Aim 2. Compare the two groups
(early vs. late) in outcomes – inhospital mortality, length of stay,
and total hospital cost

Efficiency

Aim 3. Economic evaluation of
early and late tracheostomy
among those who developed
respiratory failure with acute
Production efficiency: Combining congestive heart failure
inputs to produce services at the
exacerbation- average and
lowest cost
incremental costs with outcome
of total hospital length of stay,
and post-procedural length of
stay.

Equity

Procedural equity: Maximizing
the fairness in the distribution of
services across individuals
Substantive equity: Minimizing
the disparities in the distribution
of health across individuals

Aim 1. C. Predictors of early and
late tracheostomy will be
evaluated by multivariate logistic
regression.

Usually, these three perspectives are assessed in clinical and population level (Table 1). At
the clinical level, the analysis focuses on personal health care resources, such as technology,
expertise, equipment, and facilities. Outcomes are usually measured at a personal level. At
the population level, the analysis focuses on the improvement of population health. In this
study, we will focus on clinical analysis since the analysis will be done at an individual level.
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ABSTRACT
Background
Acute exacerbation of heart failure may result in acute respiratory failure, requiring
endotracheal intubation. For those who fail extubation, tracheostomy is indicated. However,
the optimal timing of tracheostomy among patients with acute heart failure exacerbation has
not been determined, despite multiple studies assessing the utility of early tracheostomy.
Furthermore, there is no study evaluating the benefit of early tracheostomy among patients
who are admitted with acute heart failure exacerbation.
Methods
We conducted a retrospective cohort study using National Inpatient Sample data from 2005
to 2014 to assess the trend of utilization and outcome of early tracheostomy among patients
with acute heart failure exacerbation.
Results
Among those who are admitted with acute heart failure exacerbation, 0.30% patients
underwent the tracheostomy, and among them, 9.69% received early tracheostomy. There
was no significant trend in the percentage of early tracheostomy. The length of stay in the
hospital has decreased over time in late tracheostomy group, but it was stable in early
tracheostomy group. Median total hospital length of stay (19 days) and total hospital cost
($52,158.23) in early tracheostomy group were significantly lower than late tracheostomy
group (25 days and $68,037.40).
Conclusion
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Early tracheostomy has been used in 9.69% of the patients who underwent tracheostomy with
heart failure acute exacerbation in the United States from 2005 to 2014 without any trend in
utilization. Early tracheostomy is associated with lower hospital length of stay and costs.
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INTRODUCTION
Heart failure is one of the leading causes of high morbidity and mortality. Based on the data
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That
number is anticipated to increase 46% from 2012 to 2030, which can result in more than 8
million people older than 18 years of age with heart failure. 1 Acute heart failure
exacerbation is a common but potentially fatal condition which may result in acute
respiratory failure. Once developed, the patient will need assisted ventilation. First line
treatment is a trial of noninvasive ventilation. However, if noninvasive ventilation is
contraindicated or patient fails to improve with noninvasive ventilation within 1-2 hours, the
patient should be intubated for mechanical ventilation. Despite ongoing treatment, not all the
patients can be weaned off the ventilator. In such cases, tracheostomy is indicated. 11,14
Tracheostomy is considered to be beneficial among the patients who need prolonged
mechanical ventilation, as it is thought to be more comfortable for the patients, requires less
sedation, and provides more stable airway compared to an endotracheal tube. 11 However,
tracheostomy carries several complications, such as bleeding, cardiopulmonary arrest,
hypoxia, structural damage, pneumothorax, pneumomediastinum, infection, tracheal stenosis,
granulation and erosion of the innominate artery. 11 Hence, the optimal time for tracheostomy
with the goal of getting extubated, and also to prevent complications from prolonged
intubation and to secure more stable airway, has been studied. 15,20 Some studies have shown
a benefit of early tracheostomy with shorter length of stay in the intensive care unit and
shorter duration of mechanical ventilation. However, benefit in overall mortality is still
controversial. 25-28 Furthermore, most of the studies comparing early and late tracheostomy

21

are done among trauma patients or excluded certain underlying respiratory conditions. A
specific study investigating the utilization of early tracheostomy for patients with respiratory
failure due to congestive heart failure acute exacerbation is lacking. The purpose of the study
is to assess the national trend in utilization of early tracheostomy among those who are
admitted for acute respiratory failure with acute congestive heart failure exacerbation and
assess its outcomes.

METHODS
Study subjects
We conducted a retrospective cohort study using publically accessible national survey data,
National Inpatient Sample (NIS) from 2005 to 2014. NIS is the largest all-payer inpatient
care database in the United States, which is developed by the Healthcare Cost and Utilization
Project (HCUP) 44 NIS is designed to be representative of all non-federal acute care inpatient
admissions in the United States. It contains both patient and hospital information. NIS can
approximate a 20 percent stratified sample of discharges nationwide. From the NIS dataset,
patients who are older than 17 were included for the current study. Then, patients who were
admitted with acute heart failure were selected using the International Classification of
Diseases Ninth Revision, Clinical Modification (ICD-9-CM) code. NIS data provides total 30
ICD-9-CM codes. If any of the codes for “acute” heart failure, 428.21 (acute systolic health
failure), 428.23 (acute on chronic systolic heart failure), 428.31 (acute diastolic heart failure),
428.33 (acute on chronic diastolic heart failure), 428.41 (acute combined systolic and
diastolic heart failure) and 428.43 (acute on chronic combined systolic and diastolic heart
failure) was listed in the first five diagnosis codes, that visit was considered as heart failure
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acute exacerbation related admission. We used the first five diagnosis codes out of thirty
diagnosis codes, since the diagnosis codes already had "acute" components in the diagnosis,
and tried to minimize the chances of missing samples. Then, patients who underwent
intubation were selected using ICD-9-CM codes, 96.04 (Insertion of the endotracheal tube)
and 96.05 (other intubation of respiratory tract). Also, if the patient had any of the code for
"tracheostomy," 31.1 (temporary tracheostomy), 31.2 (permanent tracheostomy), 31.21
(mediastinal tracheostomy) or 31.29 (other permanent tracheostomy) among the 15
procedural codes, then the case was selected. Early tracheostomy was defined if the
tracheostomy was performed in less than 7 days after intubation. Those who underwent
“major therapeutic surgery” based on the classification from HCUP were excluded, 45
Statistical Analysis
First, the nationally representative estimated number of tracheostomy was evaluated using
discharge weight (variable DISCWT), provided by AHRQ 46-48 . By using this weight, NIS
allows the researchers to obtain the national estimate for the variable interested. Then, ageadjusted percentages of each procedure were also plotted over time. A Cochran-Armitage test
was used to assess the trend of the percentage of tracheostomy and early tracheostomy.
Trends of the days between the intubation and the tracheostomy, total length of stay in the
hospital and total hospital cost over time were also assessed using linear regression test. All
the costs were calculated from the total hospital charges using an adjustment factor from the
provided by AHRQ. 49 Then, the costs were again adjusted to 2014 currency using consumer
price index.
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Then, the days between the intubation and the tracheostomy, total hospital costs, and total
hospital length of stay were compared between the two groups (early and late tracheostomy)
using a propensity score matching. Propensity score matching is a statistical method allowing
an observational study to estimate the effect of an intervention by controlling the covariates
in a way analogous to a randomized trial. 50,51 In this study, we used nearest neighbor 1:1
matching method using the propensity score of being assigned to early tracheostomy to
identify a matched pair. Co-variables to be used to calculate the propensity score are age, sex,
race, payers, location of the hospital (urban vs. rural) and comorbidities (coronary arterial
disease, hypertension, cerebrovascular disease, diabetes mellitus, peripheral arterial disease,
chronic obstructive pulmonary disease, cancer, liver disease, pneumonia). Comorbidities
were selected from a literature using NIS dataset assessing a cardiologic procedure and
additional significant systemic disorders. 52 and they were identified using relevant ICD-9
CM diagnosis code and Clinical Classification Software (CCS) category provided by HCUP
from the 30 diagnosis codes, which were documented at the time of discharge. 45
After matching, Mann-Whitney U test was used to compare the outcomes. Since the cost and
length of stay were not normally distributed, median with the quartiles was reported.
All analyses were conducted using STATA 14 (College Station, TX). A p-value less than
0.05 was considered as statistical significance for all tests.
Sample size calculation
Various methods for sample size calculation for trend analysis exist. Hyndman and
Kostenko, and they recommended a minimum 6 observations for yearly trend analysis, but
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Hanke recommended minimum 20 to 60 observations for trend analysis. 53,54 We will use a
sample size of 60 for trend analysis.

RESULTS
From 2005 to 2014, NIS data included total 77,394,755 patients. Among them, total
64,827,613 patients were more than 17 years old. First, we selected patients who had
diagnostic codes for acute heart failure exacerbation from the first five diagnostic codes
(1,623,013 left). Among them, 214,265 patients underwent major therapeutic surgery during
the hospitalization, and they were excluded. The 52 cases were excluded due to negative
values for length of stay and cost. Total 1,408,696 patients were included in the final
analysis. Figure 1 shows the flow chart selecting the final subjects.
Trend and percentage of tracheostomy among acute heart failure exacerbation
Among 1,408,696 eligible patients, 3,698 patients underwent tracheostomy. This is
approximately 0.30% of the total patients who were admitted with acute heart failure
exacerbation after adjusted with age. Table 1 shows the observed counts, estimated counts of
tracheostomy and the percentage of tracheostomy from the estimated counts among patients
with acute heart failure exacerbation.
Age distribution tables for each year from the United States Census were used for calculation
of age-adjusted percentage. 55 The age-adjusted percentage of tracheostomy among acute
heart failure exacerbation patients using the national estimate counts were 0.35% in 2005,
0.18% in 2006, 0.30% in 2007, 0.26% in 2008, 0.26% in 2009, 0.33% in 2010, 0.33% in
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2011, 0.36% in 2012, 0.30% in 2013, and 0.29% in 2014. (Figure 2) The percentage of
tracheostomy over time from the estimated population was stable over time (p-value 0.9268).
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Figure 1. Selection of cohort for the final analysis

Total 11,394,755 patients

Age ≤17 12,567,142 excluded

64,827,613 left
No acute heart failure
exacerbation
63,204,600 excluded
1,623,013 left

Major therapeutic surgery
214,265 excluded

1,408,748 left
Erroneous negative value of
length of stay or cost
52 excluded
1,408,696 left

1,404,998 did not receive
tracheostomy

3,698 received tracheostomy
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Table 1. Age-adjusted percentage of tracheostomy among patients with acute heart failure
exacerbation
Year

Total

Tracheostomy

Observed
counts

Weighted
counts

Observed
counts (N)

Weighted
counts (N)

Crude
percentage
(%)

Age adjusted
percentage
(%)

2005

13,742

66,713

42

206

0.31

0.35

2006

13,095

64,675

32

158

0.24

0.18

2007

25,505

127,682

46

230

0.18

0.30

2008

110,281

544,485

229

1,129

0.21

0.26

2009

157.590

799,454

376

1,915

0.24

0.26

2010

183,254

917,482

530

2,665

0.29

0.33

2011

221,170

1,063,300

653

3,157

0.30

0.33

2012

208,637

1,043,185

593

2,965

0.28

0.36

2013

226,906

1,134,530

571

2,855

0.25

0.30

2014

248,516

1,242,681

626

3,130

0.25

0.29

7,004,087

3,698

18,410

0.26

0.30

Total 1,408,696
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Figure 2. Age-adjusted percentage of tracheostomy among patients who are admitted for
acute heart failure exacerbation (%)

Age-adjusted percentage of
tracheostomy
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Trend and percentage of early tracheostomy among patients who received a tracheostomy
Among those who underwent the tracheostomy, overall 9.69% received early tracheostomy
(tracheostomy < 7 days after intubation). The age-adjusted percentage of early tracheostomy
among those who received tracheostomy during the admission with acute heart failure
exacerbation was 22.13% in 2005, 3.21% in 2006, 6.47% in 2007, 9.68% in 2008, 5.92% in
2009,10.61% in 2010, 9.40% in 2011, 10.81% in 2012, 10.57% in 2013 and 8.07% in 2014
(Table 2 and Figure 3). Due to the low sample size in the year of 2005, 2006 and 2007, they
were not included in trend analysis. From 2008 to 2014, there was no specific trend in the
percentage of early tracheostomy (p-value 0.7660).

29

Table 2. Age-adjusted percentage of early tracheostomy among patients who underwent
tracheostomy during the admission with acute heart failure exacerbation
Year

Total

Early tracheostomy

Observed
counts

Weighted
counts

Observed
counts (N)

Weighted
counts (N)

Crude
Percentage
(%)

Age-adjusted
percentage
(%)

2008

229

1,129

28

137

12.17

9.68

2009

376

1,915

35

175

9.15

5.92

2010

530

2,665

73

365

13.7

10.61

2011

653

3,157

77

371

11.75

9.40

2012

593

2,965

78

390

13.15

10.81

2013

571

2,855

86

430

15.06

10.57

2014

626

3,130

76

380

12.14

8.07

18,410

464

2,301

12.5

9.69

Total 3,698
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Figure 3. Age-adjusted percentage of early tracheostomy among patients who underwent
tracheostomy during the admission with acute heart failure exacerbation

Age-adjusted percentage of eary and late
tracheostomy
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Trend of tracheostomy day, total hospital length of stay and total hospital cost
The median length of days between intubation and tracheostomy (tracheostomy day) was 13
in late tracheostomy group, and it had a trend to decrease over time (p-value 0.025 with
coefficient factor -0.29). The median tracheostomy day was 4 in early tracheostomy group,
and there was no specific trend in tracheostomy day (p-value 0.855 and coefficient factor 0.04). The median total hospital length of stay in late tracheostomy group was 25, and it
showed a trend to decrease over time (p-value 0.042 with coefficient factor 0.89). The
median length of stay in the hospital for early tracheostomy was 19, and it has decreased over
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time (p-value 0.019 with coefficient factor -1.107). Trend analysis for early tracheostomy
group included years from 2008 to 2014 due to the low sample size in the years from 2005 to
2007. (Table 3, Figure 4 and Figure 5)
Table 3. Trend of tracheostomy day and total hospital length of stay between the two groups
Tracheostomy day

Total hospital length of stay

Late
tracheostomy

Early
tracheostomy

Late
tracheostomy

Early
tracheostomy

2005

16

3

32

18

2006

16

5

36

36

2007

13

0

23

15

2008

13

3

26

24

2009

13

4

28

22

2010

13

5

26

22

2011

13

5

24

18

2012

13

3

26

18

2013

13

3

23

16

2014

13

4

25

19

Total

13

4

25

19

p-value for
trend

0.025

0.855*

0.042

0.019*

Coefficient
factor

-0.29

-0.04

-0.89

-1.107

* Trend analysis in early tracheostomy group includes data from the year 2008 to 2014
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Figure 4. Tracheostomy day for each group
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2014

Figure 5. Total hospital length of stay for each group
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The median hospital cost was $71,181.13 in late tracheostomy group, and the median
hospital cost over time significantly decreased from 2005 to 2014 with p-value 0.008 and
coefficient factor from linear regression model -1,958.49. The median hospital cost in early
tracheostomy group was $51,573.30, and it also showed a trend to decrease over time p-value
0.002 with coefficient factor -1,994.71). (Table 4 and Figure 6)
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Table 4. Trend of total hospital cost in two groups
Late tracheostomy ($)

Early tracheostomy ($)

2005

90,755.61

61,847.87

2006

69,745.03

56,704.20

2007

80,935.66

49,311.22

2008

79,784.89

57,244.90

2009

75,339.24

58,947.73

2010

73,359.88

54,466.42

2011

71,027.15

53,242.70

2012

70,623.30

51,224.91

2013

66,135.12

46,475.97

2014

66,525.91

48,022.63

Total

71,181.13

51,573.30

p-value for trend

0.008

0.002

Coefficient factor

-1,958.49

-1,994.71

* Trend analysis in early tracheostomy group include data from year 2008 to 2014
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Figure 6. Total hospital cost for each group
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Comparison of tracheostomy day, total hospital length of stay and total hospital cost
between the two groups.
After propensity score matching, the matched cohort had 329 cases in each group. Table 5
shows the characteristics of covariates before and after matching.
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Table 5. Characteristics of covariates before and after matching
Before match

After match

Early
tracheostomy

Late
tracheostomy

N=464

N=3,234

Age (year)

66.25

66.88

Sex (%)

52.37

Non-white (%)

p-value

Early
tracheostomy

Late
tracheostomy

N=329

N=329

0.342

66.20

66.772

0.537

52.94

0.819

52.24

51.53

0.837

42.96

40.31

0.296

43.29

48.00

0.169

Non-public
insurance (%)

31.47

31.17

0.897

30.82

33.18

0.463

Urban hospital (%)

84.84

84.24

0.744

85.41

84.24

0.744

Coronary artery
disease (%)

37.50

41.47

0.104

36.94

34.35

0.431

Hypertension (%)

62.50

57.85

0.058

63.29

60.47

0.397

Cerebrovascular
disease (%)

11.42

8.94

0.084

11.06

11.77

0.747

Diabetes mellitus
(%)

43.89

39.21

0.130

43.29

43.29

>0.99

Peripheral arterial
disease (%)

4.31

5.69

0.224

4.05

4.56

0.605

Chronic obstructive
pulmonary disease
(%)

40.52

38.06

0.310

40.47

45.65

0.128

Cancer (%)

12.72

9.83

0.055

12.94

10.82

0.341

Chronic kidney
disease (%)

32.76

33.09

0.889

32.94

32.94

>0.99

Liver disease (%)

7.76

10,48

0.069

7.294

6.118

0.494

Pneumonia (%)

5.95

75.51

<0.001

66.59

69.65

0.339
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p-value

The comparison of the outcomes between the early tracheostomy group and late
tracheostomy group from the matched pair is shown at table 6. The median tracheostomy day
was significantly longer in late tracheostomy group (12 days), compared to early
tracheostomy group (4 days) with p-value <0.001. Median total hospital cost was
significantly higher in late tracheostomy group ($68,037.4) than in early tracheostomy group
($52,168.23) with p-value <0.001. Median total length of stay in the hospital was
significantly longer in late tracheostomy group (25 days) than in early tracheostomy group
(19 days) with p-value <0.001.

Table 6. Comparison of tracheostomy day, total hospital length of stay, and total hospital cost
from the matched pair
Late tracheostomy

Early tracheostomy

p-value

Median tracheostomy day
(days, quartiles)

12 (9~16)

4 (1~5)

<0.001

Median total hospital cost ($,
quartiles)

<0.001
68,037.4
52,158.23
(46,949.75~104,730.5) (36,656.73~75,114.96)

Median length of stay (days,
quartiles)

25 (18~36)

19 (13~28)

<0.001

DISCUSSION
The decision when to place a tracheostomy is not a simple procedure, and it is affected by
various factors, including the patient’s condition, the patient’s preference, the surgeon’s
preference or the hospital policy. In addition, there is no consensus or guideline for the
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optimal timing of tracheostomy. Nevertheless, a large body of literatures showed various
benefits of early tracheostomy in a different clinical setting and in different patient groups.
However, there is no study assessing the utility of early tracheostomy among patients with
acute heart failure exacerbation. Current study tried to evaluate the national trends in
tracheostomy and early tracheostomy among those who are admitted to the hospital with
acute congestive heart failure exacerbation. We also compared clinical and economic
outcomes between early tracheostomy group and late tracheostomy group.
The overall utilization of tracheostomy and early tracheostomy among the study population
has been stable over time from 2005 to 2014 from our study. There are a couple of studies
that evaluated the trend of tracheostomy in different study populations, but there is no study
evaluating the trend of early tracheostomy. Mehta et al. conducted a similar study to assess
the trend in tracheostomy for mechanically ventilated patients using NIS dataset from 1993
to 2012. 56 They reported that the utilization of tracheostomy had risen significantly over
time from 1993 to 2008 and then declined afterward. Chatterjee et al. also reported the trend
in tracheostomy after stroke using NIS dataset, and concluded that tracheostomy use has
increased from 1994 to 2013. However, their results cannot be directly compared to ours
since the study population and the time period are different. 57
Further in-depth analysis to assess the trends in other parameters of utilization of
tracheostomy showed that, in late tracheostomy group, the length of days between the
intubation and tracheostomy (tracheostomy day) decreased from 16 days (in 2005 and 2006)
to 13 days in 2014. However, after 2007, there is no specific trend, and the tracheostomy day
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had been 13 until 2014. (Table 3) The median length of stay in the hospital in both group
decreased over time (from 32 days to 25 days in late tracheostomy group and from 24 days to
19 days in early tracheostomy group).
Interestingly, the total hospital cost continued to decrease over time in both late and early
tracheostomy group. Considering the stable length of stay in both groups, this finding
suggests that the cost per day in the hospital has declined over time. It is noteworthy that
other literatures suggest the economic burden of heart failure would increase over time. 1,58
However this result should be interpreted in the context that our study population was people
who underwent tracheostomy. We conducted a subanalysis trending total hospital cost for
acute heart failure exacerbation regardless tracheostomy status, and it showed that the
hospital cost increased overtime with p-value 0.003 and coefficient factor 63.48. A possible
explanation could be more efficient care after tracheostomy or decreasing cost of the
procedure over time. However, given the limited information from the dataset, we could not
verify such a hypothesis.
We also compared the days between the intubation and the tracheostomy, total hospital cost
and total length of stay in the hospital between the two groups using propensity score
matching. We used propensity score matching to reduce the selection bias. After matching,
the outcomes were compared, and it did show a significant association of early tracheostomy
with lower total hospital cost and total length of stay in the hospital.
The current study holds several limitations. First, this study is a retrospective study using
discharge data. Even though the data is a nationally representative dataset and we used a
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propensity score matching to minimize the confounding effect of other variables, selection
bias cannot be completely eliminated. Choice of timing for tracheostomy might be affected
by the clinician's preference, the patient's decision, hospital policy or other co-existing
clinical conditions that were not captured in this study. Furthermore, the comorbidities were
identified from the discharge diagnosis code, and it is possible that the comorbidities had not
existed at the time of the decision of tracheostomy.
Second, we used first five diagnosis codes, rather than only the first diagnosis, among 30
diagnosis codes to identify the patients with acute heart failure exacerbation, to minimize the
chances to miss any case. Additionally, the etiology of respiratory failure requiring intubation
could be documented in second or third place of the diagnosis list. However, it is also
possible that the patient might have several clinical conditions to be admitted with respiratory
failure requiring intubation, such as chronic obstructive pulmonary disease or pneumonia,
which will make our study group heterogeneous. Furthermore, NIS does not provide
information regarding the severity of heart failure, which could impact the decision of early
and late tracheostomy.
Last, the sample size was fairly small for analysis. We used weight to get a national estimate,
but still, the sample size for the year of 2005, 2006 and 2007 was not enough for trend
analysis. Even though we had enough sample size for other years, the fact that they were
estimated numbers, rather than actual observations is still carries a limitation for this study.
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CONCLUSION
From 2005 to 2014, the percentage of early tracheostomy among those who underwent
tracheostomy with acute heart failure exacerbation had been stable. The length of stay in the
hospital among those who underwent early tracheostomy had been stable over time, but the
total hospital cost had been decreased. Early tracheostomy group showed a shorter length of
stay in the hospital (19 days) and less total hospital cost ($52,158.23) compared to late
tracheostomy group (25 days and $68,037.4).
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ABSTRACT
Background
Acute exacerbation of heart failure may result in acute respiratory failure, requiring
endotracheal intubation. For those who fail extubation, tracheostomy is indicated. The utility
of early tracheostomy has been studied, but not specifically for patients with acute heart
failure exacerbation.
Methods
We conducted a retrospective cohort study using National Inpatient Sample data from 2005
to 2014 to assess the predictors of early tracheostomy (<7 days after intubation) and compare
various outcomes between early and late tracheostomy group among patients with acute heart
failure exacerbation.
Results
The result from multivariate logistic regression adjusting covariables (age, sex, insurance,
hospital location, race, comorbidities) it showed that patients with coronary artery disease,
pneumonia, and liver disease are less likely to receive early tracheostomy (OR 0.79, 0.63 and
0.64 respectively). The matched pair was compared after propensity score matching, and it
showed that the two groups did not show a significant difference in in-hospital mortality (OR
0.91, p-value 0.676), or decannulation rate (OR 2.01, p-value 0.571). However, early
tracheostomy was associated with higher likelihood of having a complication from
tracheostomy with OR 2.08 (p-value 0.044) but was also associated with lower total hospital
length of stay with coefficient factor -6.50 (p-value 0.000) from linear regression model.
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Conclusion
Patients with coronary artery disease, liver disease, and pneumonia were associated lower
likelihood to receive early tracheostomy (<7 days after intubation) rather than late
tracheostomy among patients who were admitted to the hospital with acute heart failure
exacerbation. There were no other demographic factors that were associated with early
tracheostomy. When the two groups were compared using propensity score matching, they
did not differ from each other in in-hospital mortality, but clearly showed that early
tracheostomy was associated with lower total hospital length of stay.
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INTRODUCTION
Heart failure is one of the leading causes of high morbidity and mortality. Based on the data
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That
number is anticipated to increase 46% from 2012 to 2030, which can result in more than 8
million people older than 18 years of age with heart failure. 1 One in nine deaths has heart
failure on the death certificates, according to the National Center for Health Statistics in
2013. 2 Acute exacerbation of heart failure may result in acute respiratory failure, which
requires mechanical ventilator support. Despite supportive management, patients can fail
extubation of the endotracheal tube and need a tracheostomy to continue mechanical
ventilator support.
Tracheostomy usually is done to minimize the mechanical trauma to the larynx or trachea,
facilitate the weaning process, or protect the airway for a long time. Predictors of
tracheostomy have been mostly reported in trauma or surgical patients, but it has not been
studied among patients with acute respiratory failure from acute heart failure exacerbation.
Also, there has not been a study to compare the outcomes of early tracheostomy in patients
with acute heart failure exacerbation. The purpose of this study is to identify predictors of
early tracheostomy (<7 days after intubation) and compare the clinical and economic
outcomes between the two groups (early tracheostomy and late tracheostomy) among
patients who were intubated from acute heart failure exacerbation nationwide from 2005 to
2014.
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METHODS
Study subjects
We conducted a retrospective cohort study using publically accessible national survey data,
National Inpatient Sample (NIS) from 2005 to 2014. NIS is the largest all-payer inpatient
care database in the United States, which is developed by the Healthcare Cost and Utilization
Project (HCUP) 44 NIS is designed to be representative of all non-federal acute care inpatient
admissions in the United States, and it can approximate a 20 percent stratified sample of
discharges nationwide. From the NIS dataset, patients who are older than 17 were included
for the current study. Then, patients who were admitted with acute heart failure were selected
using ICD-9-CM code. NIS data provides total 30 ICD-9-CM codes. If any of the codes for
"acute" heart failure, 428.21 (acute systolic health failure), 428.23 (acute on chronic systolic
heart failure), 428.31 (acute diastolic heart failure), 428.33 (acute on chronic diastolic heart
failure), 428.41 (acute combined systolic and diastolic heart failure) and 428.43 (acute on
chronic combined systolic and diastolic heart failure) was listed for the first five diagnosis
codes, that visit was considered as heart failure acute exacerbation related admission. We
used the first five diagnosis codes out of thirty diagnosis codes, since the diagnosis codes
already had "acute" components in the diagnosis, and tried to minimize the chances of
missing samples. Then, patients who underwent intubation were selected using ICD-9-CM
codes, 96.04 (Insertion of the endotracheal tube) and 96.05 (other intubation of respiratory
tract). Also, if the patient had any of the code for "tracheostomy," 31.1 (temporary
tracheostomy), 31.2 (permanent tracheostomy), 31.21 (mediastinal tracheostomy) or 31.29
(other permanent tracheostomy), then the case was selected. Early tracheostomy was defined
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if the tracheostomy was performed within 7 days after intubation date. Those who underwent
major therapeutic surgery based on the classification from HCUP were excluded, using
ICD9-CM codes. 45
Statistical Analysis
Predictors of early and late tracheostomy were evaluated by multivariate logistic regression.
Co-variables to be used for multivariate logistic regressions are age, sex, race, payers,
location of the hospital (urban vs. rural) and comorbidities (coronary arterial disease,
hypertension, cerebrovascular disease, diabetes mellitus, peripheral arterial disease, chronic
obstructive pulmonary disease, cancer, liver disease, pneumonia). Comorbidities were
selected from the literature using NIS dataset assessing a cardiologic procedure and
additional significant systemic disorders. 52 Comorbidities were identified using relevant
ICD-9 CM diagnosis code and Clinical Classification Software (CCS) category provided by
HCUP from the 30 diagnosis codes, which were documented at the time of discharge. 45
Survey (svy) commands were used to account for the stratified sampling design of the NIS.
47,59

Then, in order to assess various clinical outcomes of early tracheostomy, total hospital length
of stay, hospital mortality, complication, and decannulation rate were compared between the
two groups (early tracheostomy group and late tracheostomy group) using a propensity score
matching. Propensity score matching is a statistical method allowing an observational study
to estimate the effect of an intervention by controlling the covariates in a way analogous to a
randomized trial. 50,51 Then a matched pair with similar propensity scores is identified, and
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the researchers compare the effect of the intervention using the selected pair. In this study,
we used nearest neighbor 1:1 matching method using the propensity score of being assigned
to early tracheostomy to identify a matched pair. Co-variables to be used to calculate the
propensity score are age, sex, race, payers, location of the hospital (urban vs rural) and
comorbidities (coronary arterial disease, hypertension, cerebrovascular disease, diabetes
mellitus, peripheral arterial disease, chronic obstructive pulmonary disease, cancer, liver
disease, pneumonia), which were used for previous multivariate logistic regression. After
propensity score matching, logistic and linear regression analysis was used to compare the
mortality, complications, decannulation and total hospital length of stay.

RESULT
Predictors of early tracheostomy among patients with acute heart failure exacerbation
We estimated the odds ratio (OR) of getting early tracheostomy with various co-variables
(Table 1).
Among various co-variables, coronary artery disease, pneumonia, and liver disease had a
significant association with the early tracheostomy, meaning patients with coronary artery
disease, pneumonia, and liver disease are less likely to receive early tracheostomy (OR 0.79,
0.63 and 0.64 respectively). Otherwise, there were no significant
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Table 1. Odds ratio of demographic and clinical characteristics for early tracheostomy

Age

Odds ratio

95% CI

p-value

1.00

0.99, 1.00

0.583

0.75, 1.15

0.522

Sex

Female

0.93

Insurance

Private

Reference

Medicare/Medicaid

0.86

0.63, 1.19

Self pay

1.03

0.56, 1.91

Other

0.91

0.43, 1.90

Hospital location

Urban

1.05

0.12, 1.42

Race

White

Reference

Black

1.10

0.86, 1.40

Hispanic

1.03

0.69, 1.53

Asian

0.85

0.32, 2.22

Native American

2.52

0.80, 7.89

Other

1.18

0.67, 2.06

Coronary arterial disease

0.79

0.63, 0.98

0.034

Hypertension

1.17

0.92, 1.47

0.200

Cerebrovascular disease

1.28

0.91, 1.77

0.165

Diabetes mellitus

1.12

0.91, 1.39

0.291

Peripheral arterial disease

0.71

0.43, 1.17

0.174

Chronic obstructive pulmonary disease 1.12

0.91, 1.39

0.281

Cancer

1.36

0.99, 1.88

0.059

Chronic kidney disease

0.87

0.69, 1.09

0.230

Liver disease

0.64

0.44, 0.95

0.026

Pneumonia

0.63

0.51, 0.79

<0.001

Comorbidities
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0.824

0.735
0.644

demographic differences in getting early tracheostomy among patients who are admitted with
acute heart failure exacerbation.
Early tracheostomy and its clinical outcomes
After propensity score matching, a matched cohort was used for analysis to assess the
association between the early tracheostomy and various clinical outcomes, total hospital
length of stay, in-hospital mortality, complication, and decannulation. Table 2 shows the
characteristics of covariates before and after matching and table 3 shows the comparison of
the outcomes between the two groups. Early tracheostomy was not significantly associated
with in-hospital mortality (OR 0.91, p-value 0.676), or decannulation (OR 2.01, p-value
0.571). However, early tracheostomy was associated with a higher likelihood of having a
complication from tracheostomy with OR 2.08 (p-value 0.044). Early tracheostomy was also
associated with less total hospital length of stay with coefficient factor -6.50 (p-value 0.000)
from linear regression model.
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Table 2. Characteristics of covariates before and after matching
Before Match

Matched pair

Early
tracheostomy

Late
tracheostomy

N=464

N=3,234

Age (year)

66.25

66.88

Sex (%)

52.37

Non-white (%)

p-value

Early
tracheostomy

Late
tracheostomy

N=329

N=329

0.342

66.20

66.772

0.537

52.94

0.819

52.24

51.53

0.837

42.96

40.31

0.296

43.29

48.00

0.169

Non-public
insurance (%)

31.47

31.17

0.897

30.82

33.18

0.463

Urban hospital (%)

84.84

84.24

0.744

85.41

84.24

0.744

Coronary artery
disease (%)

37.50

41.47

0.104

36.94

34.35

0.431

Hypertension (%)

62.50

57.85

0.058

63.29

60.47

0.397

Cerebrovascular
disease (%)

11.42

8.94

0.084

11.06

11.77

0.747

Diabetes mellitus
(%)

43.89

39.21

0.130

43.29

43.29

>0.99

Peripheral arterial
disease (%)

4.31

5.69

0.224

4.05

4.56

0.605

Chronic obstructive
pulmonary disease
(%)

40.52

38.06

0.310

40.47

45.65

0.128

Cancer (%)

12.72

9.83

0.055

12.94

10.82

0.341

Chronic kidney
disease (%)

32.76

33.09

0.889

32.94

32.94

>0.99

Liver disease (%)

7.76

10,48

0.069

7.294

6.118

0.494

Pneumonia (%)

5.95

75.51

<0.001

66.59

69.65

0.339
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p-value

Table 3. Result from regression models for clinical outcomes of early tracheostomy using the
matched cohort.
Odds Ratio

p-value

In-hospital mortality

0.91

0.676

Complication from tracheostomy

2.08

0.044

Decannulation

2.00

0.571

Coefficient factor
Total hospital length of stay

-6.5

<0.001

DISCUSSION
The current study assessed the predictors of early tracheostomy among patients who were
admitted with acute heart failure exacerbation. The results showed that coronary arterial
disease, liver disease, and pneumonia are related to lower odds ratio of getting the early
tracheostomy with odds ratio of 0.79, 0.64 and 0.63, respectively. However, there is no other
demographic factor that is significantly associated with early tracheostomy. There are few
studies that assessed the predictors of early tracheostomy, and they do not correlate with
current studies' result. A retrospective study by Brook et al. reported that male gender had a
high likelihood of getting the early tracheostomy. 40 Another retrospective study by Shaw
reported that women, black race, Hispanics, and patients with Medicaid were less likely to
receive the early tracheostomy. 60 The current study did not show any gender or racial
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differences in getting an early tracheostomy. However, the studies referred above included
heterogeneous groups, but the current study only included patients with acute heart failure
exacerbations, which may explain the different results from the other studies. Among the
comorbidities, liver disease and pneumonia could be the complications of prolonged illness
or shock, which could have served as a reason for late tracheostomy at the later stage of
hospitalization course, explaining less likelihood to get an early tracheostomy. Coronary
arterial disease is one of the major comorbidities related to heart failure, and its presence
might have delayed the decision of tracheostomy since it could prompt the physician to
pursue additional curative intervention for coronary arterial disease during that
hospitalization.
Another objective of the current study was to compare clinical outcomes between the two
groups. There was no difference in in-hospital mortality and decannulation rate between the
two groups. However, a complication from the tracheostomy was more common in early
tracheostomy group (OR 2.08 with p-value 0.044). Total hospital length of stay was
significantly different, and the early tracheostomy group had 6.5 shorter days than the late
tracheostomy group. (p-value <0.001). The mortality benefit from early tracheostomy has
been controversial based on multiple studies. However, a recent systemic review and metaanalysis by Liu et al. reported that early tracheostomy has lower short-term mortality. 31 The
current study did show less mortality in early tracheostomy group, but it was not statistically
significant. Complication from the tracheostomy was higher in early tracheostomy group in
our study. It is not consistent with the result from other studies. Young et al. reported a lower
complication rate in early tracheostomy group (5.5% in early tracheostomy group and 7.8%
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in late tracheostomy group), without statistical significance. Further studies are warranted to
compare the complication rates between the two groups since the results are not consistent
between the two studies. Early tracheostomy clearly showed a shorter total length of stay in
the hospital, shortening the length of stay by 6.5 days. Most of the previous studies
comparing early and late tracheostomy have mainly focused on the cost and length of stay in
the ICU, not the total hospital stay. 37,61 Rumbak et al. showed that early tracheostomy could
reduce the ICU stay up to 11.40 days. 37 Our study did not look into the ICU stay because of
the limitation of the information from the original dataset. However, it did confirm that the
early tracheostomy reduces the length of stay in the hospital.
The current study has several limitations. First, this study used a discharge dataset and
conducted a retrospective cohort study. Although potential confounders were adjusted
through propensity score matching and multivariate logistic regression, selection bias cannot
be completely eliminated. Choice of timing for tracheostomy can be affected by multiple
factors including the clinician's preference, the patient's decision, hospital policy or other coexisting clinical conditions, which we were not able to obtain from the dataset. However, the
result of propensity score matching actually showed that the two groups did not much differ
each other even before the matching.
Second, we identified acute heart failure exacerbation cases using the first five diagnosis
codes from total 30 diagnosis codes, rather than only the first diagnosis, We used this method
because the etiology of respiratory failure requiring intubation could be placed in second or
third place of the diagnosis list, and we wanted to maximize our sample size without missing
a case. However, it is also possible that there might be another clinical condition, which
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required intubation, such as chronic obstructive pulmonary disease, pneumonia, trauma or
surgical conditions. If it is the case, then our study group might be somewhat heterogeneous.
However, we tried to adjust such conditions through multivariate regression and propensity
score matching. We also excluded patients who underwent therapeutic surgery to avoid this
problem.
Lastly, we did not have information regarding the severity of heart failure. The severity of
heart failure affects the clinical courses and prognosis, which plays a significant role in the
decision of tracheostomy. However, we do not have such information, so we could not
stratify the patients according to the severity of the primary disease.

CONCLUSION
Despite several limitations, the current study has several strengths. It used a nationally
representative data to evaluate the predictors of early tracheostomy in patients with a specific
condition, acute heart failure exacerbation. Patients with coronary artery disease, liver
disease, and pneumonia were associated lower likelihood to receive early tracheostomy (<7
days after intubation) rather than late tracheostomy among patients who were admitted to the
hospital with acute heart failure exacerbation. There were no other demographic factors that
were associated with early tracheostomy. When the two groups were compared using
propensity score matching, they did not differ from each other in in-hospital mortality, but
clearly showed that early tracheostomy was associated with lower total hospital length of
stay.

59

REFERENCES
1. Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the
united states: A policy statement from the American heart association. Circ Heart Fail.
2013;6(3):606-619.

2. National Center for Health Statistics. Mortality multiple cause micro-data files, 2013: Publicuse data file and documentation: NHLBI tabulations.
http://www.cdc.gov.utsph.idm.oclc.org/nchs/data_access/Vitalstatsonline.htm#Mortality_Multiple.

Accessed 05/19, 2015.
3. Healthcare Cost and Utilization Project (HCUP). Overview of the national (nationwide)
inpatient sample (NIS). https://www.hcup-us.ahrq.gov/nisoverview.jsp. Updated 2018. Accessed
2/21, 2018.

4. Healthcare Cost and Utilization Project (HCUP). Clinical classifications software (CCS) for ICD9-CM. https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Updated 2017. Accessed 2/23,
2018.

5. Dhoble A, Bhise V, Nevah MI, et al. Outcomes and readmissions after transcatheter and
surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
Catheter Cardiovasc Interv. 2018;91(1):90-96.

6. Schulman AR, Abougergi MS, Thompson CC. Assessment of the July effect in post-endoscopic
retrograde cholangiopancreatography pancreatitis: Nationwide inpatient sample. World journal
of gastrointestinal endoscopy. 2017;9(7):296.

60

7. Final report on calculating national inpatient sample (NIS) variances for data years 2012 and
later. 2015. HCUP methods series report # 2015-09 . https://www.hcupus.ahrq.gov/reports/methods/2015_09.jsp. Updated 2015.

8. Rubin DB. Using propensity scores to help design observational studies: Application to the
tobacco litigation. Health Serv Outcomes Res. 2001;2(3-4):169-188.

9. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies
for causal effects. Biometrika. 1983;70(1):41-55.

10. Brook AD, Sherman G, Malen J, Kollef MH. Early versus late tracheostomy in patients who
require prolonged mechanical ventilation. American Journal of Critical Care. 2000;9(5):352.

11. Shaw JJ, Santry HP. Who gets early tracheostomy?: Evidence of unequal treatment at 185
academic medical centers. Chest. 2015;148(5):1242-1250.

12. Liu X, Wang H, Xing Y, He Y, Zhang Z, Wang T. The effect of early and late tracheotomy on
outcomes in patients: A systematic review and cumulative meta-analysis. Otolaryngology--Head
and Neck Surgery. 2014;151(6):916-922.

13. Herritt B, Chaudhuri D, Thavorn K, Kubelik D, Kyeremanteng K. Early vs. late tracheostomy
in intensive care settings: Impact on ICU and hospital costs. J Crit Care. 2018;44:285-288.

14. Rumbak MJ, Newton M, Truncale T, Schwartz SW, Adams JW, Hazard PB. A prospective,
randomized, study comparing early percutaneous dilational tracheotomy to prolonged
translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med.
2004;32(8):1689-1694.

61

JOURNAL ARTICLE III

Title of Journal: Economic Evaluation of Early and Late Tracheostomy Among Patients with
Acute Heart Failure Exacerbation
Name of Journal Proposed for Submission: JAMA Cardiology

Min Ji Kwak, MD, MS
Lincy S. Lal, PharmD, PhD
J. Michael Swint, PhD
Xianglin L. Du, MD, PhD
Wenyaw Chan, PhD
Abhijeet Dhoble, MD, MPH

62

ABSTRACT
Background
The optimal time of tracheostomy among patients with acute heart failure exacerbation has
been controversial. Several studies have proposed economic benefit from the early
tracheostomy, but no research has focused only on those with acute heart failure
exacerbation. The purpose of this study was an economic evaluation of early and late
tracheostomy among those who developed respiratory failure with acute congestive heart
failure exacerbation using average and incremental costs with the outcome of total hospital
length of stay and post-procedure length of stay.
Methods
We conducted an economic evaluation of early tracheostomy for the outcome of total
hospital length of stay and post-procedural length of stay among patients who are admitted
with acute heart failure exacerbation. We used mortality, costs, length of stay, and postprocedural length of stay from an observational study using National Inpatient Sample data
from 2005 to 2014.
Results
The early tracheostomy dominates the late tracheostomy with the outcome of total hospital
length of stay and post-procedural length of stay with lower cost and higher effectiveness.
The incremental cost-effectiveness ratio is actually negative, that is, it costs $3,492.65 dollars
for each additional day in the hospital for late tracheostomy versus early tracheostomy.
Furthermore, the average cost per effectiveness is higher in late tracheostomy group
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($2,743.43) than in the early group ($2,420.82). The average post-procedural cost per
effectiveness was $2,440.17 in late tracheostomy group and $2,591.03 in the early group.
However, the incremental cost-effectiveness ratio is again negative, at $2,032.67 dollars per
extra day in the hospital after the procedure.
Conclusions
The current study showed that early tracheostomy is more cost-effective with the outcome of
total hospital length of stay and post-procedural length of stay than late tracheostomy among
patients with acute heart failure exacerbation.
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INTRODUCTION
Heart failure is one of the leading causes of high morbidity and mortality. Based on the data
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That
number is anticipated to increase by 46% from 2012 to 2030, which can result in more than 8
million people older than 18 years of age with heart failure. 1 Considering the development
and implementation of life-prolonging interventions along with the growing elderly
population, the number of individuals with heart failure will be significantly increased, which
will also increase the cost of heart failure. 7,8 Hence, the economic burden for society is an
issue. A study using 10-year data from the National Medical Expenditure Panel Survey
(2002-2011) showed that individuals with heart failure had 4 times higher yearly expenditure
($23,854) compared to those without heart failure ($5,511) and the single largest driving
component of this increase was inpatient costs ($11,318). 8 Acute heart failure exacerbation
is one of the leading causes of hospitalization among patients with heart failure. It is also
potentially fatal, which may result in acute respiratory failure requiring intubation and
admission to the intensive care unit and mechanical ventilator care. Despite ongoing
treatment for congestive heart failure, not all the patients can be weaned off the ventilator. In
such cases, the health care providers should consider tracheostomy. 11,14 Tracheostomy is
considered to be beneficial to be more comfortable for the patients, requires less sedation,
and provides more stable airway compared to an endotracheal tube, but it still carries several
complications including bleeding, hypoxia, structural damage or cardiopulmonary arrest. 11
Hence, the optimal time for tracheostomy with the goal of getting extubated, and also to
prevent complications from prolonged intubation and to secure more stable airway, has been
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controversial. 15,20 Considering the significant economic burden of acute heart failure
exacerbation and subsequent respiratory failure requiring intubation, a strategy to determine
the optimal timing of tracheostomy should be investigated. Liu et al. reported costeffectiveness of early versus late tracheostomy with the outcome of tracheostomy prevented
and it showed that early tracheostomy could be more cost-effective with a willingness to pay
threshold of $80,000 per tracheostomy avoided. 30 Other studies have shown that early
tracheostomy may provide less mortality and fewer healthcare resources utilization.
However, most of the studies included heterogeneous clinical conditions in their outcome
assessment. Furthermore, to the best of our knowledge, studies comparing early and late
tracheostomy for patients with acute respiratory failure due to congestive heart failure are
lacking.
The purpose of this study was an economic evaluation of early and late tracheostomy among
those who developed respiratory failure with acute congestive heart failure exacerbation
using average and incremental costs with the outcome of total hospital length of stay and
post-procedure length of stay. The result of the study will provide evidence to assist both
clinicians and hospital administrator in determining the most efficient care strategy for
managing patients with respiratory failure from acute heart failure exacerbation requiring
ventilator assistance.

METHODS
We used a publically accessible national survey data, National Inpatient Sample (NIS) from
2005 to 2014 to obtain cost and effectiveness data for economic evaluation. NIS is the largest
all-payer inpatient care database in the United States, which is developed by the Healthcare
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Cost and Utilization Project (HCUP) 44 It allows the researchers to assess national estimates
of clinical and resource-use information such as diagnosis, procedures, morbidity codes,
patient’s demographic characteristics, hospital characteristics, expected payment source, total
charges, length of stay, and severity and comorbidity measures from hospital inpatient stays
in the United States. It is drawn from all states participating in HCUP and represents more
than 97 percent of the U.S. population.
Effectiveness was defined total hospital length of stay and post-procedure length of stay.
Both average and incremental cost-effectiveness ratios (ICER) were used for the economic
evaluation. With the effectiveness of hospital length of stay, ICER was calculated by
dividing incremental total hospital cost by incremental length of stay. With the effectiveness
of post-procedural length of stay, ICER was obtained using incremental post-procedural
hospital cost and incremental post-procedural length of stay.
The number of early and late tracheostomies, mortality for each intervention, the costs and
the length of stay in the hospital came from the current dataset for the base case analysis
(Table 1). The mortality was obtained from a comparative analysis using propensity score
matching. From the NIS database from 2004 to 2015, patients who were admitted with the
diagnosis of acute heart failure exacerbation were selected using ICD-9-CM codes. Patients
who were younger than 18 years old and who received therapeutic surgery were excluded
from the study. Then a matched pair, early tracheostomy group versus late tracheostomy
group, was obtained using propensity score matching adjusting covariates including age, sex,
race, payers, location of the hospital (urban vs rural) and comorbidities (coronary arterial
disease, hypertension, cerebrovascular disease, diabetes mellitus, peripheral arterial disease,
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chronic obstructive pulmonary disease, cancer, liver disease, pneumonia). We used nearest
neighbor 1:1 matching method. Early tracheostomy was defined if the patient received
tracheostomy within 7 days. Then, the mortality rate from each group was obtained from the
matched pair.
Other probabilities for the economic evaluation came from a literature review. The mean
costs and length of stay for each node were obtained using discharge weight (variable
DISCWT), provided by AHRQ. 46-48 Total hospital cost was provided by the dataset, but the
post-procedural cost was calculated by multiplying the post-procedural length of stay by
daily cost, and the daily cost was calculated by dividing the total hospital cost by the total
length of stay.
If one intervention shows higher effectiveness and lower cost, that intervention could be said
to dominate another one. 62 For example, if one intervention requires less total cost, but
resulted in a shorter stay in the hospital, then we would state that that intervention dominates
another one. The time horizon was during the admission, and discounting was not applied
because of short time horizon. This study was conducted from the U.S. health care all-payers
perspective. All costs were adjusted to 2014 U.S dollars using consumer price index.
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Table 1. Model parameters for probabilities
Variables

Value Distribution Source

Range

Probabilities
Intra-operation mortality

0.004

β

Halum et al. 63

(0~1)

Early tracheostomy, a complication related
to tracheostomy

0.054

β

Young et al. 33

(0~1)

Late tracheostomy, a complication related
to tracheostomy

0.075

β

Young et al. 33

(0~1)

Early tracheostomy, decannulation

0.51

β

Koch et al. 38

(0~1)

Late tracheostomy, decannulation

0.33

β

Koch et al. 38

(0~1)

Early tracheostomy, mortality

0.14

β

Present study

(0-1)

Late tracheostomy, mortality

0.15

β

Present study

(0-1)

Variables

Value Distribution Source

Range

Costs
Early tracheostomy, cost for each node ($)

γ

Present study

±25%

Late tracheostomy, cost for each node ($)

γ

Present study

±25%

Total hospital length of stay for each node
(days)

NA

Present study

NA

Post-procedural length of stay days for
each node (days)

NA

Present study

NA

Effects

Sensitivity analysis was conducted on probabilities and costs, using probabilistic sensitivity
analysis. The minimum value and maximum values were estimated 25% lower and 25%
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more than the mean value, respectively. There were several nodes where the dataset did not
have any case, so values (cost and effectiveness) of those nodes were substituted from the
neighboring branches. Those nodes were intra-operation mortality in early tracheostomy
(EarlyNosurvive), those with complication from the tracheostomy, and decannulated but died
in the hospital in early tracheostomy group (EarlySurviveCompDecanDeath), those with
complication from the tracheostomy, decannulated and discharged from the hospital alive in
early tracheostomy group EarlySurviveCompLive), those without complication from the
tracheostomy, and decannulated but died in the hospital in early tracheostomy group
(EarlySurviveNocompDecDeath), and those with complication from the tracheostomy, and
decannulated but died in the hospital in late tracheostomy group
(LateSurviveCompDecanDeath). The range of the probabilities was 0 to 1. A Tornado
diagram was utilized to determine the factors that had the most impact on the choice of
tracheostomy. Probabilistic sensitivity analysis was conducted using the distribution assigned
to the probabilities and costs, using a willingness to pay threshold, and the cost-effectiveness
acceptability curve was plotted. Stata/IC 14.2 was used to estimate the cost and effectiveness
from the NIS database, and TreeAge Pro program was used to construct the decision tree
model and calculate both ratios.

RESULT
Economic evaluation with the outcome of total hospital length of stay
Figure 1 shows the decision tree from the economic evaluation with the outcome of the total
hospital length of stay between the early tracheostomy and late tracheostomy. The first
economic evaluation was conducted with the outcome of the total hospital length of stay. The
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result showed that early tracheostomy dominates late tracheostomy with lower total hospital
cost and shorter total hospital length of stay (Table 2 and Figure 2). The incremental costeffectiveness ratio is actually negative, that is, it costs $3,492.65 dollars for each additional
day in the hospital for late tracheostomy versus early tracheostomy. Furthermore, the average
cost per effectiveness is higher in late tracheostomy group ($2,743.43) than in the early group
($2,420.82).
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Figure 1. Decision tree for the economic evaluation with the outcome of total hospital length of stay
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Figure 2. Cost-effectiveness analysis graph with outcome total hospital length of stay

Table 2. Cost-effectiveness analysis using outcome total hospital length of stay
Strategy

Cost

Early tracheostomy 54,489.20
Late tracheostomy

Incr Cost Eff

Incr Eff Incr C/E Average C/E

22.51

88,340.84 33,851.64 32.20

2,420.82
-9.69 -3,492.65

2,743.43

*Incr : Incremental, Eff: Effectiveness, C: Cost, E: Effectiveness
For sensitivity analysis, we performed a tornado diagram and probabilistic sensitivity
analysis. Figure 3 shows the decision tree for the sensitivity analysis. We assumed that all the
probabilities have beta distribution and costs have gamma distribution. For range, if the
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confidence interval is known from the literature, we used them, but if not, we used high as 1
and low as 0 for probability, and ±25% of the average cost.
From the tornado gram, the probability of tracheostomy-related complication in early
tracheostomy group had the highest impact on ICER resulting in a range from -3,195.03 to
4,976.14 (Figure 4). Then, we sampled 1000 observations and formulated a costeffectiveness acceptability curve. Even after the sensitivity analysis, early tracheostomy still
dominates for the effectiveness of less total length of stay in the hospital, and costeffectiveness acceptability curves do not cross over (Figure 5).
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Figure 3. Decision tree for the sensitivity analysis with the outcome of total hospital length of stay
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Figure 4. Tornado diagram of ICER using outcome total hospital length of stay

Figure 5. Cost-effectiveness acceptability curve with outcome total hospital length of stay

76

Economic evaluation with the outcome of post-procedural hospital length of stay
The second economic evaluation was conducted with the outcome of the post-procedural
length of stay, meaning the length of stay after tracheostomy. Figure 6 shows the decision
tree with the outcome of post-procedural length of stay. The result showed that early
tracheostomy again dominates late tracheostomy with lower post-procedural hospital cost
and shorter post procedural hospital length of stay (Table 3 and Figure 7). The average cost
per effectiveness was $2,440.17 in late tracheostomy group and $2,591.03 in the early group.
However, the incremental cost-effectiveness ratio is again negative, at $2,032.67 dollars per
extra day in the hospital after the procedure.
Table 3. Cost-effectiveness analysis using outcome post-procedural length of stay
Strategy

Cost

Early tracheostomy 46,366.49
Late tracheostomy

Incr Cost Eff
0 17.89

59,832.38 13,465.89 24.52

Incr Eff Incr C/E C/E
0

0 2,591.03

-6.62 -2,032.67 2,440.17

*Incr : Incremental, Eff: Effectiveness, C: Cost, E: Effectiveness
Again, for sensitivity analysis, we performed a tornado diagram and probabilistic sensitivity
analysis. We assumed that all the probabilities have beta distribution and costs have gamma
distribution. For range, if the confidence interval is known from the literature, we used them,
but if not, we used high as 1 and low as 0 for probability, and ±25% of the average cost.
From the tornado gram, the probability of complication after tracheostomy among patients
who underwent late tracheostomy had the highest impact on ICER resulting in a range from 7,075.09 to -1,561.15 (Figure 9). Then, we sampled 1000 observations and formulated a

77

cost-effectiveness acceptability curve. Even after the sensitivity analysis, again, early
tracheostomy still dominates for the effectiveness of less post-procedural length of stay in the
hospital, and cost-effectiveness acceptability curves do not cross over (Figure 10).
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Figure 6. Decision tree with the outcome of post-procedural length of stay

79

Figure 7. Cost-effectiveness analysis graph with outcome post-procedural length of stay
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Figure 8. Decision tree for sensitivity analysis with outcome of post-procedural length of stay
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Figure 9. Tornado diagram of ICER using outcome post-procedural length of stay

Figure 10. Cost-effectiveness acceptability curve using the outcome post procedural length of
stay
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DISCUSSION
The current study evaluated the cost-effectiveness of early tracheostomy using the outcome
of total hospital length of stay, and post-procedural length of stay. For both outcomes, early
tracheostomy dominated late tracheostomy. It had a lower cost with less hospital length of
stay. Even after sensitivity analysis, early tracheostomy remains to dominate late
tracheostomy with a willingness to pay up to $100,000.
We particularly chose the length of stay as the outcome of the economic evaluation since
previous studies have shown very controversial results for mortality differences between
early and late tracheostomy, but somewhat consistent results for less health care utilization in
early tracheostomy group. Furthermore, from our own analysis of NIS dataset, mortality rates
from the two interventions were incorporated into the decision tree as probabilities and
reflected the final economic analysis.
To the best of our knowledge, there has been only one economic evaluation study assessing
early tracheostomy. Liu et al. reported cost-effectiveness of early versus late tracheostomy
with the outcome of tracheostomy prevented and it showed that early tracheostomy could be
more cost-effective with a willingness to pay threshold of $80,000 per tracheostomy avoided.
30

However, this study focused on the cost-effectiveness per tracheostomy avoided, not

health care utilization such as length of stay. Several other studies have reported less health
care resources utilization among early tracheostomy group with various medical or surgical
conditions, proposing less intensive care unit stay or shorter ventilation dependent days. 25,27
However, the current study is the first study to perform cost-effectiveness analysis using
outcomes of hospital length of stay among patients who are admitted with acute heart failure
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exacerbation. Furthermore, the cost and effectiveness information came from real patients
data, rather than literature review or expert opinion, and it makes the result of evaluation
more credible.
However, the current study holds several limitations. First, even though the mortality, cost,
and effectiveness were derived from real patients' data, the result is still from a retrospective
cohort study, not a randomized controlled study. The information still could be confounded
by selection bias. However, we tried to reduce its effect by sensitivity analysis. When
performing sensitivity analysis, for the probability we used the widest range possible, from 0
to 1, and still, the result showed that early tracheostomy dominates the late tracheostomy.
Second, based on the decision tree, each node should have its own cost and effectiveness
from the database, but some nodes did not have any sample from the database since the
sample size was small. In such cases, we used the cost and effectiveness from the
neighboring nodes for sensitivity analysis. Hence, the tree does not reflect the real clinical
situation, but we tried to overcome it through sensitivity analysis.
Last, for the economic analysis with the outcome of post-procedural length of stay, we used
the estimated cost that was calculated by the daily cost ((Total hospital cost/total length of
stay) * post-procedural length of stay). It may not reflect the actual cost after the procedure,
since the patient care after the procedure may be significantly different. However, due to the
limitation of the dataset and information availability, we tried to use the best alternative.

84

CONCLUSION
The current study showed that early tracheostomy is more cost-effective with the outcome of
total hospital length of stay and post-procedural length of stay than late tracheostomy among
patients with acute heart failure exacerbation.
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APPENDIX
APPENDIX A. Variable values for cost effectiveness analysis with outcome of total hospital
length of stay
Name
cEarlyNosurvive
cEarlySurviveCompDecanDeath
cEarlySurviveCompDecanLive
cEarlySurviveCompNodecanDeath
cEarlySurviveCompNodecanLive
cEarlySurviveNocompDecanDeath
cEarlySurviveNocompDecanLive
cEarlySurviveNocompNodecanDeath
cEarlySurviveNocompNodecanLive
cLateNosurvive
cLateSurviveCompDecanDeath
cLateSurviveCompDecanLive
cLateSurviveCompNodecanDeath
cLateSurviveCompNodecanLive
cLateSurviveNocompDecanDeath
cLateSurviveNocompDecanLive
cLateSurviveNocompNodecanDeath
cLateSurviveNocompNodecanLive
eEarlyNosurvive
eEarlySurviveCompDecanDeath
eEarlySurviveCompDecanLive
eEarlySurviveCompNodecanDeath
eEarlySurviveCompNodecanLive
eEarlySurviveNocompDecanDeath
eEarlySurviveNocompDecanLive
eEarlySurviveNocompNodecanDeath
eEarlySurviveNocompNodecanLive
eLateNosurvive
eLateSurviveCompDecanDeath
eLateSurviveCompDecanLive
eLateSurviveCompNodecanDeath
eLateSurviveCompNodecanLive
eLateSurviveNocompDecanDeath
eLateSurviveNocompDecanLive
eLateSurviveNocompNodecanDeath
eLateSurviveNocompNodecanLive

Root Definition
0
0
0
71,984.93
66,896.56
0
59,604.39
67,579.37
59,709.12
44,235.01
0
128,999.90
114,616.60
97,910.96
91,305.28
90,299.62
105,054.60
82,785.89
0
0
0
21.91
21.64
0
23.33
23.30
23.23
12.20
0
38.46
42.08
32.83
43
38.41
34.75
29.64
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APPENDIX B. Variable values for PSA with outcome of total hospital length of stay
Name
cEarlyNosurvive
cEarlySurviveCompDecanDeath
cEarlySurviveCompDecanLive
cEarlySurviveCompNodecanDeath
cEarlySurviveCompNodecanLive
cEarlySurviveNocompDecanDeath
cEarlySurviveNocompDecanLive
cEarlySurviveNocompNodecanDeath
cEarlySurviveNocompNodecanLive
cLateNosurvive
cLateSurviveCompDecanDeath
cLateSurviveCompDecanLive
cLateSurviveCompNodecanDeath
cLateSurviveCompNodecanLive
cLateSurviveNocompDecanDeath
cLateSurviveNocompDecanLive
cLateSurviveNocompNodecanDeath
cLateSurviveNocompNodecanLive
eEarlyNosurvive
eEarlySurviveCompDecanDeath
eEarlySurviveCompDecanLive
eEarlySurviveCompNodecanDeath
eEarlySurviveCompNodecanLive
eEarlySurviveNocompDecanDeath
eEarlySurviveNocompDecanLive
eEarlySurviveNocompNodecanDeath
eEarlySurviveNocompNodecanLive
eLateNosurvive
eLateSurviveCompDecanDeath
eLateSurviveCompDecanLive
eLateSurviveCompNodecanDeath
eLateSurviveCompNodecanLive
eLateSurviveNocompDecanDeath
eLateSurviveNocompDecanLive
eLateSurviveNocompNodecanDeath
eLateSurviveNocompNodecanLive

Root Definition
44,235.01
128,999.90
128,999.90
71,984.93
66,896.56
59,604.39
59,604.39
67,579.37
59,709.12
44,235.01
128,999.90
128,999.90
114,616.60
97,910.96
91,305.28
90,299.62
105,054.60
82,785.89
12.20
38.46
38.46
21.91
21.64
23.33
23.33
23.30
23.23
12.20
38.46
38.46
42.08
32.83
43.00
38.41
34.75
29.64
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APPENDIX C. Variable values for cost effectiveness analysis with outcome of post
procedural length of stay
Name

Root Definition

cEarlySurviveCompDecanDeath
cEarlySurviveCompDecanLive
cEarlySurviveCompNodecanDeath
cEarlySurviveCompNodecanLive
cEarlySurviveNocompDecanDeath
cEarlySurviveNocompDecanLive
cEarlySurviveNocompNodecanDeath
cEarlySurviveNocompNodecanLive
cLateSurviveCompDecanDeath
cLateSurviveCompDecanLive
cLateSurviveCompNodecanDeath
cLateSurviveCompNodecanLive
cLateSurviveNocompDecanDeath
cLateSurviveNocompDecanLive
cLateSurviveNocompNodecanDeath
cLateSurviveNocompNodecanLive
eEarlySurviveCompDecanDeath
eEarlySurviveCompDecanLive
eEarlySurviveCompNodecanDeath
eEarlySurviveCompNodecanLive
eEarlySurviveNocompDecanDeath
eEarlySurviveNocompDecanLive
eEarlySurviveNocompNodecanDeath
eEarlySurviveNocompNodecanLive
eLateNosurvive
eLateSurviveCompDecanDeath
eLateSurviveCompDecanLive
eLateSurviveCompNodecanDeath
eLateSurviveCompNodecanLive
eLateSurviveNocompDecanDeath
eLateSurviveNocompDecanLive
eLateSurviveNocompNodecanDeath
eLateSurviveNocompNodecanLive

0
0
57,102.66
58,334.76
0
50,796.8
56,880.93
50,320.07
0
70,357.85
63,794.57
63,886.94
61,577.98
85,435.52
62,135.93
46,248.49
0
0
18.05
18.61
0
19.67
19.99
19.94
0
0
21.69
26.64
21.08
29
41.30
21.15
17.05
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APPENDIX D. Variable values for PSA with outcome of post-procedural length of stay
Name
cEarlySurviveCompDecanDeath
cEarlySurviveCompDecanLive
cEarlySurviveCompNodecanDeath
cEarlySurviveCompNodecanLive
cEarlySurviveNocompDecanDeath
cEarlySurviveNocompDecanLive
cEarlySurviveNocompNodecanDeath
cEarlySurviveNocompNodecanLive
cLateSurviveCompDecanDeath
cLateSurviveCompDecanLive
cLateSurviveCompNodecanDeath
cLateSurviveCompNodecanLive
cLateSurviveNocompDecanDeath
cLateSurviveNocompDecanLive
cLateSurviveNocompNodecanDeath
cLateSurviveNocompNodecanLive
eEarlySurviveCompDecanDeath
eEarlySurviveCompDecanLive
eEarlySurviveCompNodecanDeath
eEarlySurviveCompNodecanLive
eEarlySurviveNocompDecanDeath
eEarlySurviveNocompDecanLive
eEarlySurviveNocompNodecanDeath
eEarlySurviveNocompNodecanLive
eLateSurviveCompDecanDeath
eLateSurviveCompDecanLive
eLateSurviveCompNodecanDeath
eLateSurviveCompNodecanLive
eLateSurviveNocompDecanDeath
eLateSurviveNocompDecanLive
eLateSurviveNocompNodecanDeath
eLateSurviveNocompNodecanLive

Root Definition
70,357.85
70,357.85
57,102.66
58,334.76
50,796.80
50,796.80
56,880.93
50,320.07
70,357.85
70,357.85
63,794.57
63,886.94
61,577.98
85,435.52
62,135.93
46,248.49
21.69
21.69
18.05
18.61
19.67
19.67
19.99
19.94
21.69
21.69
26.64
21.08
29
41.30
21.15
17.05
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